Invasive ductal carcinoma of the breast: Correlation between tumor grade determined by ultrasound-guided core biopsy and surgical pathology

American Journal of Roentgenology

Volumn 200, Issue 1, 2013, Pages

  Zheng, Jiamin ^a   Alsaadi, Tahra ^a   Blaichman, Jason ^a   Xie, Xuanqian ^a   Omeroglu, Attila ^a   Meterissian, Sarkis ^a   Mesurolle, Benoît ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Breast cancer; Breast surgery; Invasive ductal carcinoma; Tumor grade; Ultrasound guided biopsy

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; CANCER GRADING; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE GUIDED BIOPSY; MAJOR CLINICAL STUDY; NEEDLE BIOPSY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR VOLUME; ULTRASOUND GUIDED CORE NEEDLE BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, LARGE-CORE NEEDLE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM GRADING; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84871894854     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.11.7461     Document Type: Article

References (24)

1. Parker SH, Jobe WE, Dennis MA, et al. US-guided automated large-core breast biopsy. Radiology 1993; 187:507-511 (Pubitemid 23127863)
2. Liberman L, Feng TL, Dershaw DD, Morris EA, Abramson AF. US-guided core breast biopsy: use and cost-effectiveness. Radiology 1998; 208:717-723 (Pubitemid 28405108)
3. Liberman L. Clinical management issues in percutaneous core breast biopsy. Radiol Clin North Am 2000; 38:791-807 (Pubitemid 30640066)
4. Pijnappel RM, van den Donk M, Holland R, et al. Diagnostic accuracy for different strategies of image-guided breast intervention in cases of non-palpable breast lesions. Br J Cancer 2004; 90:595-600 (Pubitemid 38297196)
5. Harris GC, Denley HE, Pinder SE, et al. Correlation of histologic prognostic factors in core biopsies and therapeutic excisions of invasive breast carcinoma. Am J Surg Pathol 2003; 27:11-15 (Pubitemid 36014894)
6. Sharifi S, Peterson MK, Baum JK, Raza S, Schnitt SJ. Assessment of pathologic prognostic factors in breast core needle biopsies. Mod Pathol 1999; 12:941-945 (Pubitemid 29485266)
7. Badoual C, Maruani A, Ghorra C, Lebas P, Avigdor S, Michenet P. Pathological prognostic factors of invasive breast carcinoma in ultrasound-guided large core biopsies: correlation with subsequent surgical excisions. Breast 2005; 14:22-27 (Pubitemid 40197823)
8. Denley H, Pinder SE, Elston CW, Lee AH, Ellis IO. Preoperative assessment of prognostic factors in breast cancer. J Clin Pathol 2001; 54:20-24 (Pubitemid 32048290)
9. Pinder SE, Murray S, Ellis IO, et al. The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy. Cancer 1998; 83:1529-1539 (Pubitemid 28465470)
10. Page DL, Gray R, Allred DC, et al. Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry: an Eastern Cooperative Oncology Group Study (2192). Am J Clin Oncol 2001; 24:10-18 (Pubitemid 32178665)
11. Contesso G, Mouriesse H, Friedman S, Genin J, Sarrazin D, Rouesse J. The importance of histologic grade in long-term prognosis of breast cancer: a study of 1,010 patients, uniformly treated at the Institut Gustave-Roussy. J Clin Oncol 1987; 5:1378-1386
12. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. Part I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19:403-410
13. Neville AM, Bettelheim R, Gelber RD, et al. Factors predicting treatment responsiveness and prognosis in node-negative breast cancer: The International (Ludwig) Breast Cancer Study Group. J Clin Oncol 1992; 10:696-705
14. Huober J, von Minckwitz G, Denkert C, et al. Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study. Breast Cancer Res Treat 2010; 124:133-140
15. Untch M, Fasching PA, Konecny GE, et al. PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel ± darbepoetin alfa in primary breast cancer - results at the time of surgery. Ann Oncol 2011; 22:1988-1998
16. Maur M, Guarneri V, Frassoldati A, Conte PF. Primary systemic therapy in operable breast cancer: clinical data and biological fall-out. Ann Oncol 2006; 17:v158-v164 (Pubitemid 43985227)
17. Shet T, Agrawal A, Chinoy R, Havaldar R, Parmar V, Badwe R. Changes in the tumor grade and biological markers in locally advanced breast cancer after chemotherapy: implications for a pathologist. Breast J 2007; 13:457-464 (Pubitemid 47329332)
18. Richter-Ehrenstein C, Mueller S, Noske A, Schneider A. Diagnostic accuracy and prognostic value of core biopsy in the management of breast cancer: a series of 542 patients. Int J Surg Pathol 2009; 17:323-326
19. Shannon J, Douglas-Jones AG, Dallimore NS. Conversion to core biopsy in preoperative diagnosis of breast lesions: is it justified by results? J Clin Pathol 2001; 54:762-765 (Pubitemid 32929497)
20. O'Leary R, Hawkins K, Beazley JC, Lansdown MR, Hanby AM. Agreement between preoperative core needle biopsy and postoperative invasive breast cancer histopathology is not dependent on the amount of clinical material obtained. J Clin Pathol 2004; 57:193-195 (Pubitemid 38177762)
21. Fitzgibbons PL, Connolly JL, Page DL; Members of the Cancer Committee, College of American Pathologists. Breast: protocol applies to all invasive carcinomas of the breast. College of American Pathologists website. www.cap.org/apps/docs/cancer-protocols/2005/breast05-pw.pdf. Published 2005. Accessed August 28, 2012
22. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33:159-174 (Pubitemid 8054849)
23. Usami S, Moriya T, Amari M, et al. Reliability of prognostic factors in breast carcinoma determined by core needle biopsy. Jpn J Clin Oncol 2007; 37:250-255 (Pubitemid 47090677)
24. McIlhenny C, Doughty JC, George WD, Mallon EA. Optimum number of core biopsies for accurate assessment of histological grade in breast cancer. Br J Surg 2002; 89:84-85 (Pubitemid 34031313)